EGM
ATRS

Engineers Gate Manager’s Antares Pharma, Inc. ATRS Stock Holding History

Engineers Gate Manager’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,697
Closed -$122K – 2392
2022
Q1 		$122K Sell
29,697
-10,467
-26% -$38K ﹤0.01% 1683
2021
Q4 		$143K Buy
40,164
+15,216
+61% +$53.2K 0.01% 1743
2021
Q3 		$91K Sell
24,948
-29,193
-54% -$118K 0.01% 1542
2021
Q2 		$236K Sell
54,141
-61,766
-53% -$252K 0.02% 1299
2021
Q1 		$476K Sell
115,907
-21,276
-16% -$92.2K 0.02% 1025
2020
Q4 		$547K Buy
137,183
+13,235
+11% +$42.8K 0.02% 922
2020
Q3 		$335K Sell
123,948
-8,196
-6% -$22.7K 0.02% 1189
2020
Q2 		$363K Sell
132,144
-24,523
-16% -$68.4K 0.02% 1118
2020
Q1 		$370K Sell
156,667
-21,030
-12% -$71.5K 0.03% 934
2019
Q4 		$835K Buy
+177,697
New +$727K 0.04% 737

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's ATRS Position: Q2 2022 in Review

Engineers Gate Manager sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 29,697 shares — an estimated $122K sold.

Engineers Gate Manager first reported a position in ATRS in Q4 2019 and held it in 10 quarters. The position peaked at $835K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Engineers Gate Manager reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 29,697 Antares Pharma, Inc. shares in Q2 2022, an estimated $122K.
  • Engineers Gate Manager first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 10 quarters.
  • Engineers Gate Manager's Antares Pharma, Inc. position peaked at $835K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Engineers Gate Manager's 13F filing for Q2 2022, filed 15 Aug 2022.